References

• Ademokun, A., Wu, Y. C., & Dunn-Walters, D. (2009). The ageing B cell population: Composition and function. Biogerontology, 11(2), 125-137.
• Alinejad, V., Dolati, S., Motallebnezhad, M., & Yousefi, M. (2017). The role of IL17B- IL17RB signaling pathway in breast cancer. Biomedicine & Pharmacotherapy, 88, 795-803. doi:
• Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., Powell, J. I., Yang, L., Marti, G. E., Moore, T., Hudson, J., Lu, L., Lewis, D. B., Tibshirani, R., Sherlock, G., . . . Staudt, L. M. (2000). Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403(6769), 503-511.
• Asano, N., Watanabe, T., Kitani, A., Fuss, I. J., & Strober, W. (2008). Notch1 Signaling and Regulatory T Cell Function. The Journal of Immunology, 180(5), 2796-2804.
• Blackadar, C. B. (2016). Historical review of the causes of cancer. World Journal of Clinical Oncology, 7(1), 54.
• Bodmer, W. F. (1994). Cancer genetics. British Medical Bulletin, 50(3), 517-526.
• Bommireddy, R., & Doetschman, T. (2007). TGFβ1 and Treg cells: alliance for tolerance. Trends in Molecular Medicine, 13(11), 492-501. doi:
• Borsellino, G., Kleinewietfeld, M., Di Mitri, D., Sternjak, A., Diamantini, A., Giometto, R., . . . Falk, K. (2007). Expression of ectonucleotidase CD39 by Foxp3 Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood, 110(4), 1225- 1232. doi:
• Busse, D., de la Rosa, M., Hobiger, K., Thurley, K., Flossdorf, M., Scheffold, A., & Höfer, T. (2010). Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments. Proceedings of the National Academy of Sciences, 107(7), 3058-3063.
• Cao, X., Cai, S. F., Fehniger, T. A., Song, J., Collins, L. I., Piwnica-Worms, D. R., & Ley, T. J. (2007). Granzyme B and Perforin Are Important for Regulatory T Cell- Mediated Suppression of Tumor Clearance. Immunity, 27(4), 635-646. doi:
• Chang, M. H. (2000). Natural history of hepatitis B virus infection in children. Journal of Gastroenterology and Hepatology, 15(5 (Suppl.)), E16-E19.
• Chang, S. H., Mirabolfathinejad, S. G., Katta, H., Cumpian, A. M., Gong, L., Caetano, M. S., Moghaddam, S. J., & Dong, C. (2014). T helper 17 cells play a critical pathogenic role in lung cancer. Proceedings of the National Academy of Sciences, 111(15), 5664-5669.
• Chehimi, M., Vidal, H., & Eljaafari, A. (2017). Pathogenic Role of IL-17-Producing Immune Cells in Obesity, and Related Inflammatory Diseases. Journal of Clinical Medicine, 6(7), 68.
• Cheng, G., Yu, A., & Malek, T. R. (2011). T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells. 241(1), 63-76. doi:
• Chinen, T., Kannan, A. K., Levine, A. G., Fan, X., Klein, U., Zheng, Y., Gasteiger, G., Feng, Y., Fontenot, J. D., & Rudensky, A. Y. (2016). An essential role for the IL-2 receptor in Treg cell function. Nature Immunology, 17(11), 1322-1333.
• Clapp, R. W., Jacobs, M. M., & Loechler, E. L. (2008). Environmental and Occupational Causes of Cancer: New Evidence 2005- 2007. Reviews on Environmental Health, 23(1), 1-38.
• Coffelt, S. B., Kersten, K., Doornebal, C. W., Weiden, J., Vrijland, K., Hau, C. S., Verstegen, N. J. M., Ciampricotti, M., Hawinkels, L. J. A. C., Jonkers, J., & de Visser, K. E. (2015). IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. Nature, 522(7556), 345-348.
• Collison, L. W., Chaturvedi, V., Henderson, A. L., Giacomin, P. R., Guy, C., Bankoti, J., Finkelstein, D., Forbes, K., Workman, C. J., Brown, S. A., Rehg, J. E., Jones, M. L., Ni, H. T., Artis, D., Turk, M. J., & Vignali, D. A. A. (2010). IL-35-mediated induction of a potent regulatory T cell population. Nature Immunology, 11(12), 1093-1101.
• Collison, L. W., Workman, C. J., Kuo, T. T., Boyd, K., Wang, Y., Vignali, K. M., Cross, R., Sehy, D., Blumberg, R. S., & Vignali, D. A. A. (2007). The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature, 450(7169), 566-569.
• Coronella-Wood, J. A., & Hersh, E. M. (2003). Naturally occurring B-cell responses to breast cancer. Cancer Immunology, Immunotherapy, 52(12), 715-738.
• Cunningham, D., Hawkes, E. A., Jack, A., Qian, W., Smith, P., Mouncey, P., Pocock, C., Ardeshna, K. M., Radford, J. A., McMillan, A., Davies, J., Turner, D., Kruger, A., Johnson, P., Gambell, J., & Linch, D. (2013). Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles. The Lancet, 381(9880), 1817-1826.
• Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., Zhu, Y., Wei, S., Kryczek, I., Daniel, B., Gordon, A., Myers, L., Lackner, A., Disis, M. L., Knutson, K. L., . . . Zou, W. (2004). Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature Medicine, 10(9), 942-949.
• Davis, R. E., Ngo, V. N., Lenz, G., Tolar, P., Young, R. M., Romesser, P. B., Kohlhammer, H., Lamy, L., Zhao, H., Yang, Y., Xu, W., Shaffer, A. L., Wright, G., Xiao, W., Powell, J., Jiang, J. K., Thomas, C. J., Rosenwald, A., Ott, G., . . . Staudt, L. M. (2010). Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature, 463(7277), 88-92.
• Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J. F., Enjyoji, K., Linden, J., Oukka, M., Kuchroo, V. K., Strom, T. B., & Robson, S. C. (2007). Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. Journal of Experimental Medicine, 204(6), 1257- 1265.
• Dedobbeleer, O., Stockis, J., van der Woning, B., Coulie, P. G., & Lucas, S. (2017). Cutting Edge: Active TGF-β1 Released from GARP/TGF-β1 Complexes on the Surface of Stimulated Human B Lymphocytes Increases Class-Switch Recombination and Production of IgA. The Journal of Immunology, 199(2), 391-396.
• Elkord, E., Alcantar-Orozco, E. M., Dovedi, S. J., Tran, D. Q., Hawkins, R. E., & Gilham, D. E. (2010). T regulatory cells in cancer: recent advances and therapeutic potential. Expert Opinion on Biological Therapy, 10(11), 1573-1586.
• Ernst, M., & Putoczki, T. (2014). IL-17 Cuts to the Chase in Colon Cancer. Immunity, 41(6), 880-882. doi:
• Facciabene, A., Peng, X., Hagemann, I. S., Balint, K., Barchetti, A., Wang, L. P., Gimotty, P. A., Gilks, C. B., Lal, P., Zhang, L., & Coukos, G. (2011). Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells. Nature, 475(7355), 226-230.
• Franzese, O., Kennedy, P. T. F., Gehring, A. J., Gotto, J., Williams, R., Maini, M. K., & Bertoletti, A. (2005). Modulation of the CD8 -T-Cell Response by CD4 CD25 Regulatory T Cells in Patients with Hepatitis B Virus Infection. Journal of Virology, 79(6), 3322-3328.
• Garcia-Hernandez, M. L., Hernandez-Pando, R., Gariglio, P., & Berumen, J. (2002). Interleukin-10 promotes B16-melanoma growth by inhibition of macrophage functions and induction of tumour and vascular cell proliferation. Immunology, 105(2), 231-243.
• Gavin, M. A., Rasmussen, J. P., Fontenot, J. D., Vasta, V., Manganiello, V. C., Beavo, J. A., & Rudensky, A. Y. (2007). Foxp3- dependent programme of regulatory T- cell differentiation. Nature, 445(7129), 771-775.
• Ghiringhelli, F., MéNard, C., Terme, M., Flament, C., Taieb, J., Chaput, N., Puig, P. E., Novault, S., Escudier, B., Vivier, E., Lecesne, A., Robert, C., Blay, J. Y., Bernard, J., Caillat-Zucman, S., Freitas, A., Tursz, T., Wagner-Ballon, O., Capron, C., . . . Zitvogel, L. (2005). CD4 CD25 regulatory T cells inhibit natural killer cell functions in a transforming growth factor- β-dependent manner. Journal of Experimental Medicine, 202(8), 1075- 1085.
• Hemdan, N. Y. A. (2013). Anti-cancer versus cancer-promoting effects of the interleukin-17-producing T helper cells. Immunology Letters, 149(1), 123- 133doi:
• Hu, Z., Luo, D., Wang, D., Ma, L., Zhao, Y., & Li, L. (2017). IL-17 Activates the IL-6/STAT3 Signal Pathway in the Proliferation of Hepatitis B Virus-Related Hepatocellular Carcinoma. Cellular Physiology and Biochemistry, 43(6), 2379-2390.
• Huber, S., Schramm, C., Lehr, H. A., Mann, A., Schmitt, S., Becker, C., Protschka, M., Galle, P. R., Neurath, M. F., & Blessing, M. (2004). Cutting Edge: TGF-β Signaling Is Required for the In Vivo Expansion and Immunosuppressive Capacity of Regulatory CD4 CD25 T Cells. The Journal of Immunology, 173(11), 6526- 6531.
• Hussain, S. P., Hofseth, L. J., & Harris, C. C. (2003). Radical causes of cancer. Nature Reviews Cancer, 3(4), 276-285.
• Ishida, T., Ishii, T., Inagaki, A., Yano, H., Komatsu, H., Iida, S., Inagaki, H., & Ueda, R. (2006). Specific Recruitment of CC Chemokine Receptor 4-Positive Regulatory T Cells in Hodgkin Lymphoma Fosters Immune Privilege. Cancer Research, 66(11), 5716-5722.
• Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., . . . Littman, D. R. (2006). The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17 T Helper Cells. Cell, 126(6), 1121-1133. doi:
• Jin, P., Ren, H., Sun, W., Xin, W., Zhang, H., & Hao, J. (2014). Circulating IL-35 in pancreatic ductal adenocarcinoma patients. Human Immunology, 75(1), 29- 33. doi:
• Jordan, M. S., Boesteanu, A., Reed, A. J., Petrone, A. L., Holenbeck, A. E., Lerman, M. A., Naji, A., & Caton, A. J. (2001). Thymic selection of CD4 CD25 regulatory T cells induced by an agonist self-peptide. Nature Immunology, 2(4), 301-306.
• Kanzler, H., Küppers, R., Hansmann, M. L., & Rajewsky, K. (1996). Hodgkin and Reed- Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. Journal of Experimental Medicine, 184(4), 1495- 1505.
• Karimi-Googheri, M., Daneshvar, H., Nosratabadi, R., Zare-Bidaki, M., Hassanshahi, G., Ebrahim, M., Arababadi, M. K., & Kennedy, D. (2013). Important roles played by TGF-β in hepatitis B infection. Journal of Medical Virology, 86(1), 102-108.
• Kobie, J. J., Shah, P. R., Yang, L., Rebhahn, J. A., Fowell, D. J., & Mosmann, T. R. (2006). T Regulatory and Primed Uncommitted CD4 T Cells Express CD73, Which Suppresses Effector CD4 T Cells by Converting 5′-Adenosine Monophosphate to Adenosine. The Journal of Immunology, 177(10), 6780- 6786.
• Küppers, R. (2008). The biology of Hodgkin's lymphoma. Nature Reviews Cancer, 9(1), 15-27.
• Küppers, R., Rajewsky, K., Zhao, M., Simons, G., Laumann, R., Fischer, R., & Hansmann, M. L. (1994). Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proceedings of the National Academy of Sciences, 91(23), 10962-10966.
• Küppers, R., Zhao, M., Hansmann, M. L., & Rajewsky, K. (1993). Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. 12(13), 4955- 4967. doi:
• Li, Q., Grover, A. C., Donald, E. J., Carr, A., Yu, J., Whitfield, J., Nelson, M., Takeshita, N., & Chang, A. E. (2005). Simultaneous Targeting of CD3 on T Cells and CD40 on B or Dendritic Cells Augments the Antitumor Reactivity of Tumor-Primed Lymph Node Cells. The Journal of Immunology, 175(3), 1424-1432.
• Liu, V. C., Wong, L. Y., Jang, T., Shah, A. H., Park, I., Yang, X., Zhang, Q., Lonning, S., Teicher, B. A., & Lee, C. (2007). Tumor Evasion of the Immune System by Converting CD4 CD25 T Cells into CD4 CD25 T Regulatory Cells: Role of Tumor-Derived TGF-β. The Journal of Immunology, 178(5), 2883-2892.
• Loder, B. F., Mutschler, B., Ray, R. J., Paige, C. J., Sideras, P., Torres, R., Lamers, M. C., & Carsetti, R. (1999). B Cell Development in the Spleen Takes Place in Discrete Steps and Is Determined by the Quality of B Cell Receptor-Derived Signals. Journal of Experimental Medicine, 190(1), 75-90.
• Lossos, I. S., Alizadeh, A. A., Eisen, M. B., Chan, W. C., Brown, P. O., Botstein, D., Staudt, L. M., & Levy, R. (2000). Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proceedings of the National Academy of Sciences, 97(18), 10209- 10213.
• Malek, T. R. (2008). The Biology of Interleukin- 2. Annual Review of Immunology, 26(1), 453-479.
• Mandapathil, M., Hilldorfer, B., Szczepanski, M. J., Czystowska, M., Szajnik, M., Ren, J., . . . Whiteside, T. L. (2010). Generation and Accumulation of Immunosuppressive Adenosine by Human CD4 CD25highFOXP3 Regulatory T Cells*. Journal of Biological Chemistry, 285(10), 7176-7186. doi:
• Marshall, E. A., Ng, K. W., Kung, S. H. Y., Conway, E. M., Martinez, V. D., Halvorsen, E. C., Rowbotham, D. A., Vucic, E. A., Plumb, A. W., Becker-Santos, D. D., Enfield, K. S. S., Kennett, J. Y., Bennewith, K. L., Lockwood, W. W., Lam, S., English, J. C., Abraham, N., & Lam, W. L. (2016). Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis. Molecular Cancer, 15(1).
• Meeker, T. C., Lowder, J., Maloney, D. G., Miller, R. A., Thielemans, K., Warnke, R., & Levy, R. (1985). A Clinical Trial of Anti- Idiotype Therapy for B Cell Malignancy. Blood, 65(6), 1349-1363. doi:
• Murai, M., Turovskaya, O., Kim, G., Madan, R., Karp, C. L., Cheroutre, H., & Kronenberg, M. (2009). Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nature Immunology, 10(11), 1178-1184.
• Nurieva, R. I., Chung, Y., Hwang, D., Yang, X. O., Kang, H. S., Ma, L., . . . Dong, C. (2008). Generation of T Follicular Helper Cells Is Mediated by Interleukin-21 but Independent of T Helper 1, 2, or 17 Cell Lineages. Immunity, 29(1), 138-149. doi:
• Ohta, A., & Sitkovsky, M. (2014). Extracellular Adenosine-Mediated Modulation of Regulatory T Cells. Frontiers in Immunology, 5.
• Pan, B., Shen, J., Cao, J., Zhou, Y., Shang, L., Jin, S., Cao, S., Che, D., Liu, F., & Yu, Y. (2015). Interleukin-17 promotes angiogenesis by stimulating VEGF production of cancer cells via the STAT3/GIV signaling pathway in non- small-cell lung cancer. Scientific Reports, 5(1).
• Petanidis, S., Anestakis, D., Argyraki, M., Hadzopoulou-Cladaras, M., & Salifoglou, A. (2013). Differential Expression of IL-17, 22 and 23 in the Progression of Colorectal Cancer in Patients with K-ras Mutation: Ras Signal Inhibition and Crosstalk with GM-CSF and IFN-γ. PLoS ONE, 8(9), e73616.
• Pylayeva-Gupta, Y. (2016). Molecular Pathways: Interleukin-35 in Autoimmunity and Cancer. Clinical Cancer Research, 22(20), 4973-4978.
• Reth, M., & Nielsen, P. (2014). Chapter Four - Signaling Circuits in Early B-Cell Development. In F. W. Alt (Ed.), Advances in Immunology 122, 129-175, Academic Press.
• Rickert, R. C. (2013). New insights into pre-BCR and BCR signalling with relevance to B cell malignancies. Nature Reviews Immunology, 13(8), 578-591.
• Romagnani, S. (1992). Type 1 T helper and type 2 T helper cells: Functions, regulation and role in protection and disease. International Journal of Clinical & Laboratory Research, 21(2-4), 152-158.
• Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., Hurt, E. M., Zhao, H., Averett, L., Yang, L., Wilson, W. H., Jaffe, E. S., Simon, R., Klausner, R. D., Powell, J., . . . Staudt, L. M. (2002). The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma. New England Journal of Medicine, 346(25), 1937-1947.
• Sawant, D. V., Yano, H., Chikina, M., Zhang, Q., Liao, M., Liu, C., Callahan, D. J., Sun, Z., Sun, T., Tabib, T., Pennathur, A., Corry, D. B., Luketich, J. D., Lafyatis, R., Chen, W., Poholek, A. C., Bruno, T. C., Workman, C. J., & Vignali, D. A. A. (2019). Adaptive plasticity of IL-10 and IL-35 Treg cells cooperatively promotes tumor T cell exhaustion. Nature Immunology, 20(6), 724-735.
• Seifert, M., Scholtysik, R., & Küppers, R. (2013). Origin and Pathogenesis of B Cell Lymphomas. In R. Küppers (Ed.), Lymphoma: Methods and Protocols (pp. 1-25). Totowa, NJ: Humana Press.
• Seo, N., Hayakawa, S., Takigawa, M., & Tokura, Y. (2001). Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4 T-regulatory cells and systemic collapse of antitumour immunity. Immunology, 103(4), 449-457.
• Seoane, J., & Gomis, R. R. (2017). TGF-β Family Signaling in Tumor Suppression and Cancer Progression. Cold Spring Harbor Perspectives in Biology, 9(12), a022277.
• Shaffer, A. L., Young, R. M., & Staudt, L. M. (2012). Pathogenesis of Human B Cell Lymphomas. Annual Review of Immunology, 30(1), 565-610.
• Shah, S., Divekar, A. A., Hilchey, S. P., Cho, H.- M., Newman, C. L., Shin, S.-U., . . . Rosenblatt, J. D. (2005). Increased rejection of primary tumors in mice lacking B cells: Inhibition of anti-tumor CTL and TH1 cytokine responses by B cells. 117(4), 574-586. doi:
• Sitkovsky, M., Lukashev, D., Deaglio, S., Dwyer, K., Robson, S. C., & Ohta, A. (2008). Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells. 153(S1), S457-S464. doi:
• Song, Y., & Yang, J. M. (2017). Role of interleukin (IL)-17 and T-helper (Th)17 cells in cancer. Biochemical and Biophysical Research Communications, 493(1), 1-8. doi:
• Sorrentino, R., Morello, S., Forte, G., Montinaro, A., Vita, G. D., Luciano, A., Palma, G., Arra, C., Maiolino, P., Adcock, I. M., & Pinto, A. (2011). B Cells Contribute to the Antitumor Activity of CpG- Oligodeoxynucleotide in a Mouse Model of Metastatic Lung Carcinoma. American Journal of Respiratory and Critical Care Medicine, 183(10), 1369-1379.
• Stockis, J., Fink, W., François, V., Connerotte, T., de Smet, C., Knoops, L., . . . Lucas, S. (2009). Comparison of stable human Treg and Th clones by transcriptional profiling. 39(3), 869-882. doi:
• Stoop, J. N., van der Molen, R. G., Kuipers, E. J., Kusters, J. G., & Janssen, H. L. A. (2007). Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B. Virology, 361(1), 141-148. doi:
• Strauss, L., Bergmann, C., Szczepanski, M., Gooding, W., Johnson, J. T., & Whiteside, T. L. (2007). A Unique Subset of CD4 CD25high Foxp3 T Cells Secreting Interleukin-10 and Transforming Growth Factor-β1 Mediates Suppression in the Tumor Microenvironment. Clinical Cancer Research, 13(15), 4345-4354.
• Su, Z. J., Yu, X. P., Guo, R. Y., Ming, D. S., Huang, L. Y., Su, M. L., Deng, Y., & Lin, Z. Z. (2013). Changes in the balance between Treg and Th17 cells in patients with chronic hepatitis B. Diagnostic Microbiology and Infectious Disease,76(4), 437-444.
• Thornton, A. M., Lu, J., Korty, P. E., Kim, Y. C., Martens, C., Sun, P. D., & Shevach, E. M. (2019). Helios and Helios Treg subpopulations are phenotypically and functionally distinct and express dissimilar TCR repertoires. 49(3), 398-412. doi:
• Tilly, H., Gomes da Silva, M., Vitolo, U., Jack, A., Meignan, M., Lopez-Guillermo, A., . . . Ladetto, M. (2015). Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Annals of Oncology, 26, v116-v125. doi:
• Trehanpati, N., & Vyas, A. K. (2017). Immune Regulation by T Regulatory Cells in Hepatitis B Virus-Related Inflammation and Cancer. Scandinavian Journal of Immunology, 85(3), 175-181.
• Trehanpati, N., Shrivastav, S., Shivakumar, B., Khosla, R., Bhardwaj, S., Chaturvedi, J., Sukriti, Kumar, B., Bose, S., Tripathi, D. M., Das, T., Sakhuja, P., Rastogi, A., Bhihari, C., Singh, S., Gupta, S., Kottilil, S., & Sarin, S. K. (2012). Analysis of Notch and TGF-β Signaling Expression in Different Stages of Disease Progression During Hepatitis B Virus Infection. Clinical and Translational Gastroenterology, 3(10), e23.
• Turnis, M. E., Sawant, D. V., Szymczak- Workman, A. L., Andrews, L. P., Delgoffe, G. M., Yano, H., . . . Vignali, D. A. A. (2016). Interleukin-35 Limits Anti-Tumor Immunity. Immunity, 44(2), 316-329. doi:
• Venkitaraman, A. R., Williams, G. T., Dariavach, P., & Neuberger, M. S. (1991). The B-cell antigen receptor of the five immunoglobulin classes. Nature, 352(6338), 777-781.
• Vignali, D. A. A., Collison, L. W., & Workman, C. J. (2008). How regulatory T cells work. Nature Reviews Immunology, 8(7), 523- 532.
• Voron, T., Marcheteau, E., Pernot, S., Colussi, O., Tartour, E., Taieb, J., & Terme, M. (2014). Control of the Immune Response by Pro- Angiogenic Factors. Frontiers in Oncology, 4.
• Wang, L., Yi, T., Kortylewski, M., Pardoll, D. M., Zeng, D., & Yu, H. (2009). IL-17 can promote tumor growth through an IL-6- Stat3 signaling pathway. Journal of Experimental Medicine, 206(7), 1457- 1464.
• Wang, S., Gao, X., Shen, G., Wang, W., Li, J., Zhao, J., Wei, Y. Q., & Edwards, C. K. (2016). Interleukin-10 deficiency impairs regulatory T cell-derived neuropilin-1 functions and promotes Th1 and Th17 immunity. Scientific Reports, 6(1).
• Young, R. M., Wu, T., Schmitz, R., Dawood, M., Xiao, W., Phelan, J. D., Xu, W., Menard, L., Meffre, E., Chan, W. C. C., Jaffe, E. S., Gascoyne, R. D., Campo, E., Rosenwald, A., Ott, G., Delabie, J., Rimsza, L. M., & Staudt, L. M. (2015). Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens. Proceedings of the National Academy of Sciences, 112(44), 13447-13454.
• Yu, X., Guo, R., Ming, D., Su, M., Lin, C., Deng, Y., Lin, Z., & Su, Z. (2014). Ratios of regulatory T cells/T-helper 17 cells and transforming growth factor- β1/interleukin-17 to be associated with the development of hepatitis B virus- associated liver cirrhosis. Journal of Gastroenterology and Hepatology, 29(5), 1065-1072.
• Zarek, P. E., Huang, C. T., Lutz, E. R., Kowalski, J., Horton, M. R., Linden, J., Drake, C. G., & Powell, J. D. (2008). A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood, 111(1), 251-259.
• Zhao, D. M., Thornton, A. M., DiPaolo, R. J., & Shevach, E. M. (2006). Activated CD4 CD25 T cells selectively kill B lymphocytes. Blood, 107(10), 3925-3932.
• Zheng, S. G., Wang, J., Wang, P., Gray, J. D., & Horwitz, D. A. (2007). IL-2 Is Essential for TGF-β to Convert Naive CD4 CD25 Cells to CD25 Foxp3 Regulatory T Cells and for Expansion of These Cells. The Journal of Immunology, 178(4), 2018- 2027.
• Zhu, X., & Zhu, J. (2020). CD4 T Helper Cell Subsets and Related Human Immunological Disorders. International Journal of Molecular Sciences, 21(21), 8011.